Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

HCA HEALTHCARE, INC.

(HCA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

HCA Healthcare, Inc. : There is still some upside potential

01/13/2022 | 02:54am EST
long trade
Live
Entry price : 249.92$ | Target : 295$ | Stop-loss : 223.5$ | Potential : 18.04%
HCA Healthcare, Inc.'s shares display attractive technical aspects to anticipate a comeback of the underlying trend.
Investors have an opportunity to buy the stock and target the $ 295.
HCA Healthcare, Inc. : HCA Healthcare, Inc. : There is still some upside potential
Summary
  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths
  • The company has a low valuation given the cash flows generated by its activity.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Sales forecast by analysts have been recently revised upwards.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses
  • The group shows a rather high level of debt in proportion to its EBITDA.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart
Subsector Other Healthcare Facilities & Services
1st jan.Capitalization (M$)Investor Rating
HCA HEALTHCARE, INC.-7.39%74 002
CVS HEALTH CORPORATION-0.75%134 161
LABORATORY CORPORATION OF A..-13.79%25 989
FRESENIUS MEDICAL CARE AG &..1.61%19 294
QUEST DIAGNOSTICS INCORPORA..-20.72%16 895
DR. SULAIMAN AL HABIB MEDIC..4.09%15 675
REDE D'OR SÃO LUIZ S.A.-6.27%15 219
DAVITA INC.-3.84%11 147
UNIVERSAL HEALTH SERVICES, ..-1.01%10 316
TENET HEALTHCARE CORPORATIO..-7.00%8 138
CHEMED CORPORATION-11.06%7 213
More Results

ę MarketScreener.com 2022

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (USD)
Sales 2021 59 073 M - -
Net income 2021 6 462 M - -
Net Debt 2021 32 162 M - -
P/E ratio 2021 11,9x
Yield 2021 0,80%
Capitalization 74 002 M 74 002 M -
EV / Sales 2021 1,80x
EV / Sales 2022 1,72x
Nbr of Employees 235 000
Free-Float 77,1%
Upcoming event on HCA HEALTHCARE, INC.
01/27/22
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Last Close Price 237,93 $
Average target price 283,87 $
Spread / Average Target 19,3%
EPS Revisions
Managers and Directors
Samuel N. Hazen President, CEO, Chief Operating Officer & Director
William B. Rutherford CFO, Chief Accounting Officer & Executive VP
Thomas Fearn Frist Chairman
P. Martin Paslick VP-Information Technology & Services
Kathleen M. Whalen Senior VP, Chief Ethics & Compliance Officer